Icahn ramps up rhetoric on Illumina after FTC orders Grail sale
In a letter to Illumina shareholders, Icahn says the two companies “should be separated immediately” to protect the “long term growth prospects and viability of each.”
Some patients still pay for ACA-mandated free preventative care, study finds
Last week, the Biden Administration filed a notice to appeal a federal court ruling that blocked the ACA mandate that requires health plans to fully cover preventative medical services like cancer, HIV and diabetes screenings.
Cano board members resign, call for CEO’s termination amid ‘decimated’ stock and ‘crippling’ debt
Cano Health, a value-based primary care provider for seniors, has found itself embroiled in a boardroom drama after three of its board members publicly resigned last week.
Telehealth use rose for third straight month in January among privately insured
Fair Health, which recently began tracking audio-only telehealth data, also found that audio-only utilization fell nationally from December to January.
Sanford, Fairview delay merger indefinitely; Minnesota AG continues review of deal
The state attorney general’s office has cautioned against a quick merger since the deal was first announced in November.
Provider groups push back on planned nursing home staff mandates
In the letter, two hospital groups argue that federal staffing mandates are a “one-size-fits-all” approach to the labor crisis and that issuing mandates would further reduce capacity by forcing some nursing homes to shut their doors.
Study finds ‘ubiquitous’ third-party tracking on hospital websites, compromising user data
Almost 99% of hospital websites include tracking software that transfer data to third parties, including technology and social media companies, data brokers, advertisers and even private equity firms, a new study found.
Illumina ordered to divest Grail by FTC on anticompetition concerns
The San Diego-based DNA-sequencing company, which also faces a challenge from European antitrust regulators, said it will appeal the FTC’s order.
UnitedHealth executive returns to company 6 months after leaving for CVS
Amar Desai is back at UnitedHealth as senior adviser to its CEO Andrew Witty.
CMS increases MA rate bump for 2024
Risk adjustment changes will now be phased in over three years, after payers pushed back on the proposed payment rule.